Search Results - "Remington, G.J."

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    The adrenergic α2 antagonist atipamezole alters the behavioural effects of pramipexole and increases pramipexole concentration in blood plasma

    The adrenergic α2 antagonist atipamezole alters the behavioural effects of pramipexole and increases pramipexole concentration in blood plasma by McCormick, P.N., Fletcher, P.J., Wilson, V.S., Remington, G.J.

    Published in Life sciences (1973) (15-04-2016)
    “…Pramipexole is a dopaminergic agonist used in Parkinson's disease treatment. It is thought to exert its therapeutic and side effects through actions on…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Low dose pramipexole causes D3 receptor-independent reduction of locomotion and responding for a conditioned reinforcer

    Low dose pramipexole causes D3 receptor-independent reduction of locomotion and responding for a conditioned reinforcer by McCormick, P.N., Fletcher, P.J., Wilson, V.S., Browne, J.D.C., Nobrega, J.N., Remington, G.J.

    Published in Neuropharmacology (01-02-2015)
    “…Pramipexole is a clinically important dopamine receptor agonist with reported selectivity for dopamine D3 receptors over other dopaminergic and…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    An educational intervention designed to improve treatment adherence in schizophrenia

    An educational intervention designed to improve treatment adherence in schizophrenia by Collins, A., Remington, G.J.

    Published in Schizophrenia research (01-03-2003)
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    Perceptions of sexual functioning, prolactin levels and psychopathology in an olanzapine switch trial

    Perceptions of sexual functioning, prolactin levels and psychopathology in an olanzapine switch trial by Dickson, R.A., Glazer, W.M., Remington, G.J., Stip, E., Walker, D.J., Luther, M., Jones, B.

    Published in Schizophrenia research (01-03-2003)
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    Serial measurement of sexual function using the DGSFi in an olanzapine switch trial

    Serial measurement of sexual function using the DGSFi in an olanzapine switch trial by Dickson, R.A., Violato, C., Smekal, T., Glazer, W.M., Remington, G.J., Stip, E., Walker, D.J., Jones, B.

    Published in European neuropsychopharmacology (01-10-2002)
    Get full text
    Journal Article
    Save to List
    Saved in:
  6. 6
    58. The receptor occupancy of olanzapine assessed with pet: Theoretical and clinical implications

    58. The receptor occupancy of olanzapine assessed with pet: Theoretical and clinical implications by Kapur, S., Zipurksy, R.B., Remington, G.J., Jones, C., Houle, S.

    Published in Biological psychiatry (1969) (01-04-1998)
    Get full text
    Journal Article
    Save to List
    Saved in:
  7. 7
    Increase in dopamine D 2 receptor binding following long-term treatment with neuroleptics in humans

    Increase in dopamine D 2 receptor binding following long-term treatment with neuroleptics in humans by Silvestri, S., Seeman, M.V., Negrete, J.C., Houle, S., Shammi, C.M., Remington, G.J., Kapur, S., Zipursky, R.B., Wilson, A., Christensen, B.K., Seeman, P.

    Published in Schizophrenia research (2000)
    Get full text
    Journal Article
    Save to List
    Saved in:
  8. 8
    Increase in dopamine D2 receptor binding following long-term treatment with neuroleptics in humans

    Increase in dopamine D2 receptor binding following long-term treatment with neuroleptics in humans by Silvestri, S., Seeman, M.V., Negrete, J.C., Houle, S., Shammi, C.M., Remington, G.J., Kapur, S., Zipursky, R.B., Wilson, A., Christensen, B.K., Seeman, P.

    Published in Schizophrenia research (01-01-2000)
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: